Abstract
Mumps, caused by the mumps virus (MuV), remains a significant public health challenge, particularly among children and adolescents. Despite widespread vaccination, local outbreaks persist globally. This study investigates the potential mismatch between current vaccines (typically Genotype A or B) and circulating strains. By analyzing MuV sequences from 1995 to 2019, researchers found that while Genotype G dominates globally, Genotype F is the primary strain in China. The study highlights a low genetic mutation rate for Genotype F but a concerning rebound in its population dynamics, underscoring the need for next-generation vaccines tailored to local genotypes.
Introduction: The Challenge of Vaccine Mismatch
Mumps is often perceived as a controlled disease, yet outbreaks in highly vaccinated populations suggest a growing gap in immunity. The mumps virus (MuV) is classified into at least 12 genotypes (A–N). Most current vaccines utilize strains isolated decades ago, such as Genotype A or B. If circulating strains diverge significantly from these vaccine strains, the neutralization efficacy of vaccine-induced antibodies may be compromised. This study focuses on the evolutionary history and population dynamics of MuV in China to determine why the disease persists despite robust immunization programs.
Methodology
The research team utilized a comprehensive bioinformatics pipeline to map the virus's evolution across global and local datasets.
The analysis involved several key steps:
- Phylogenetic Reconstruction: Maximum Likelihood (ML) trees were constructed using the Small Hydrophobic (SH) gene—the international standard for MuV nomenclature—and non-coding regions (NCR).
- Molecular Clock Modeling: Bayesian Markov chain Monte Carlo (MCMC) methods were used to estimate the time to most recent common ancestor (tMRCA) and substitution rates.
- Population Dynamics: Bayesian Skyline Plots (BSP) visualized changes in the virus's effective population size over time, which were then correlated with clinical case reports from the National Notifiable Diseases Reporting System (NNDRS).
The study analyzed 932 complete genomes and 111 representative SH gene sequences globally, alongside 418 SH gene sequences collected across 22 Chinese provinces between 1995 and 2019.
Key Results and Insights
Geographic Divergence and Genotype F Dominance
A primary finding is the stark contrast between global and domestic MuV trends. While Genotype G is the most prevalent strain worldwide, Genotype F is overwhelmingly dominant in China, accounting for over 97% of the Chinese sequences studied (406 out of 418).
Evolutionary Stability and Origin
Molecular clock analysis indicates that current Genotype F strains in China likely originated in Shanghai around 1989 (tMRCA ~1989.69). Despite its long-term persistence, the virus exhibits a relatively low mutation rate ($2.02 \times 10^{-3}$ substitutions per site per year). This stability suggests that the persistence of mumps in China is not due to rapid viral "escape" mutations, but rather an inherent mismatch with the Genotype A-based S79 vaccine strain currently in use.
Population Dynamics and the "Rebound" Trend
Analysis of clinical data and viral population size revealed a significant peak in cases between 2011 and 2012 (approx. 479,500 cases). While cases declined through 2015, a notable "rebound" began in 2017. Although the COVID-19 pandemic caused a temporary drop in reported cases due to non-pharmaceutical interventions (like masking), the underlying trend suggests that MuV remains a persistent threat as these measures ease.
Conclusion: Toward Next-Generation Vaccines
The continued dominance of Genotype F in China, coupled with its genetic distance from standard vaccine strains, supports the urgent development of genotype-specific vaccines. Incorporating Genotype F or G into future immunization programs could provide the broader cross-protective immunity necessary to eliminate mumps outbreaks. Future efforts should focus on the clinical evaluation of these next-generation candidates to ensure long-term public health security.
Summary updated